Lexicon Pharma (LXRX) Reports Q4 EPS of $0.76
Tweet
Share
E-mailGet Alerts LXRX Hot Sheet
Price: $2.18 --0%
Revenue Growth %: -78.9%
Financial Fact:
Loss from operations: -34.93M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: -78.9%
Financial Fact:
Loss from operations: -34.93M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Lexicon Pharma (NASDAQ: LXRX) reported Q4 EPS of $0.76, versus ($0.03) reported last year. Revenue for the quarter came in at $127.3 million, versus $21.5 million reported last year.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- TD Cowen on Alaska Air (ALK): 'Can Alaska ReAccelerate?'
- Cracker Barrel (CBRL) Tops Q4 EPS by 89c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
